Given the established link between obesity-associated lipid dysregulation increased breast cancer risk [27, 28], FABP4 and FABP5 play critical roles in facilitating fatty acid oxidation and metabolism, as well as promoting oncogenic lipid signaling pathways. This evidence concerns the gene FABP5 and obesity due to melanocortin 4 receptor deficiency.